US Patent Issued to SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE on March 4 for "Nucleoporins as drug targets for anti-proliferative therapeutics" (California Inventor)

ALEXANDRIA, Va., March 5 -- United States Patent no. 12,239,656, issued on March 4, was assigned to SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE (La Jolla, Calif.).

"Nucleoporins as drug targets for anti-proliferative therapeutics" was invented by Maximiliano D'Angelo (San Diego).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein are methods of inhibiting nuclear pore complex assembly and inducing nuclear pore complex disassembly. Methods to screen for agents that inhibit nuclear pore assembly or induce nuclear pore complex disassembly are also disclosed."

The patent was filed on Nov. 22, 2022, under Application No. 18/058,212.

*For further information, including images, charts and tables...